Picture of Clinica Baviera SA logo

CBAV Clinica Baviera SA Share Price

0.000.00%
es flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m+13.57%
3m+14.49%
6m+16.85%
1yr+30.87%
Volume Change (%)
10d/3m+8.89%
Price vs... (%)
52w High-3.41%
50d MA+10.43%
200d MA+29.21%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)14.88
PEG Ratio (f)0.19
EPS Growth (f)345.46%
Dividend Yield (f)5.12%
Valuation (ttm)IndustryMarket
Price to Book Value5.07
Price to Tang. Book6.26
Price to Free Cashflow13.12
Price to Sales2.05
EV to EBITDA6.17

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital37.55%
Return on Equity45.43%
Operating Margin22.27%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m124.33122.63172.73198.45224.9222322715.53%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+8.19+8.88+96.8+9.92-99.88+84515.38+7.49n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Clinica Baviera SA EPS forecast chart

Profile Summary

Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The Company operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 31st, 1992
Public Since
January 1st, 2000
No. of Employees
1,349
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
es flag iconMadrid Stock Exchange
Shares in Issue
16,291,970
Blurred out image of a map
Address
Paseo de la Castellana 20, MADRID, 28046
Web
https://www.clinicabaviera.com/
Phone
+34 917819880
Auditors
PricewaterhouseCoopers Auditores SL

CBAV Share Price Performance

Upcoming Events for CBAV

Q1 2024 Clinica Baviera SA Earnings Release

Q2 2024 Clinica Baviera SA Earnings Release

Similar to CBAV

Picture of Atrys Health SA logo

Atrys Health SA

es flag iconMadrid Stock Exchange

Picture of Euroespes SA logo

Euroespes SA

es flag iconMadrid Stock Exchange

FAQ